Table 4.
RSV n = 310 | Other n = 217 | p-value | |
---|---|---|---|
Age (days) | 77.98 (± 58.02) | 78.80 (± 64.16) | ns |
Males (%) | 45.8 | 54.83 | ns |
LOS (days) | 4.98 (± 2.18) | 4.22 (± 2.16) | <0.001 |
Total cost (€) | 1,783,562.76 | 1,170,746.54 | |
Mean cost (€) | 5,753.43 (± 2,041.62) | 5,395.15 (± 2,040.87) | 0.04 |
Imaging (€) | 18.95 (± 28.62) | 16.00 (± 26.41) | ns |
Laboratory (€) | 3,486.38 (± 1,126.19) | 3,454.70 (± 1,204.50) | ns |
PICU (%) | 4.19 | 2.30 | ns |
Among all patients (n. 531), four were not tested for respiratory virus infection. Data are shown as the number of cases (%) or mean (± SD).